News

A peptide called pNaKtide has shown promise in improving the clinical manifestations associated with non-alcoholic fatty liver disease (NAFLD) and atherosclerosis, according to researchers at Marshall…

The U.S. Food and Drug Administration has granted orphan drug status to cabozantinib for the treatment of hepatocellular carcinoma, the most common type of liver cancer.

Type 2 diabetes increases the risk of a person getting a severe liver disease, including cancer, regardless of their body mass index (BMI) reading, research…

Researchers from Stony Brook University have described a biochemical mechanism that occurs in the liver and is responsible for the conversion of a lipid…

A study of obese, diabetic mice found that vibrating their entire bodies for 20 minutes daily for three months reduced their body fat and insulin…

Scientists have long believed that liver cancer cells needed fat molecules to survive, and that by blocking fat production, the cancer would starve. But a new Australian…

Drinking coffee may reduce the risk of chronic liver disease, especially in patients with other conditions affecting the liver, including non-alcoholic fatty liver disease, according…

A recent study has suggested that nonalcoholic fatty liver disease (NAFLD) may contribute to increased rates of hospital readmission in patients suffering from heart failure.

Focused ultrasound appears to be able to selectively destroy liver tumors, new research from an EU project shows. Preliminary results of this new method, developed…

The tiny spheres, or microvesicles (MVs), released from liver cells and macrophages seem to be key players in the progression of non-alcoholic fatty liver disease…